Results showed a reduction in infarct size compared with conventional PCI in STEMI patients with large thrombus burden. Results were presented as Late-Breaking Science at ESC Congress 2026. DALLAS, Texas, Aug. 29, 2026 /PRNewswire/ -- Vesalio today announced results from the NATURE trial...
Hence then, the article about nature randomized controlled trial meets primary endpoint evaluating envast assisted mechanical thrombectomy in large thrombus stemi was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( NATURE Randomized Controlled Trial Meets Primary Endpoint Evaluating enVast-Assisted Mechanical Thrombectomy in Large-Thrombus STEMI )
Also on site :
- INTCO Medical meldet für das erste Halbjahr 2026 ein Umsatzwachstum von 40,6 % und baut die weltweit größte Produktionskapazität für Einweghandschuhe auf 107 Milliarden Stück aus
- I Tried Every Single Disney Vacation Club Perk—Here’s What Disney’s Most Exclusive Club Is Really Like
- Red Sox reportedly ‘very likely’ to activate Roman Anthony ahead of Sunday’s series finale vs. Yankees